ISPE Midyear 2017
nav line

Preliminary Agenda

Embracing the Future: Ensuring Opportunities Become Reality

Click here to view final program.

Saturday
April 1, 2017

9:00am - 5:00pm

ISPE Board of Directors Meeting

Members are encouraged to contact staff if interested in attending the Board meeting

Sunday
April 2, 2017

7:00 am - 6:00 pm Registration open
8:00am - Noon PRE-CONFERENCE COURSE: Introduction to Pharmacoepidemiology
(Additional Registration Required)


Brief overview of course:
This half-day course will provide participants with a short introduction to the basic principles and concepts of pharmacoepidemiology. The course includes lectures on cohort studies, case-control studies, and bias & confounding.

Educational Objectives:
  • Explain common study designs used in pharmacoepidemiology and appreciate their strengths and weaknesses.
  • Describe the key steps in the design and analysis of cohort and case-control studies.
  • Understand the major types of biases that threaten the validity of pharmacoepidemiologic research (confounding, selection bias, measurement bias).
Target Audience:
  • Attendees who are new to pharmacoepidemiology or those who want a succinct refresher of the field's core concepts.
Presentations
  • Almut Winterstein, FISPE, University of Florida College of Pharmacy, Cohort Studies
  • Jennifer Lund, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Case-Control Studies
  • Tobias Gerhard, FISPE, Ernest Mario School of Pharmacy, Rutgers University, Bias & Confounding
8:30am - 12:00pm 2017 ICPE Scientific Program Committee meeting
12:00pm - 1:30pm Lunch on your own
1:30pm - 5:30pm PRE-CONFERENCE COURSE: Advanced Topics in Pharmacoepidemiology
(Additional Registration Required)

  • Using simulation studies to evaluate statistical methods
  • Propensity scores - over-hyped or underused?
  • What to do when data are going missing?
  • Using the parametric Waiting Time Distribution to estimate prescription durations

Click here to read a description of the sessions and presenters.

5:30pm -7:00pm Welcome Reception (Included in symposioum registration)

Monday
April 3, 2017
Scientific Symposium

Symposium Overview
With the advent of the Internet of Things, ubiquitous smart phones, and social media playing such a large role in peoples' lives, there is increasing opportunity for citizens to generate data relating to health, but do we capture such data and is it useful to us for pharmacoepidemiology? There is evolving interest in combining novel patient generated information with conventional Real Word Data generated from medical systems, and this meeting addresses how much insight the new data delivers and how acceptable it is for drug safety and outcomes research.

7:30am - 5:00 pm Registration
9:30am - 9:40am Welcome

Kiyoshi Kubota, FISPE, ISPE President
Alison Bourke, FISPE, Chair, ISPE 2017 Mid-Year Planning Committee

9:40am - 10:25am

Will Dixon, Professor of Digital Epidemiology, Manchester University
Overview - New sources of data

10:25am - 11:10am Jenni Quint, Clinical Senior Lecturer in Respiratory Epidemiology, Imperial Research using wearables/environmental detectors
11:10am - 11:40am Break
11:40am - 12:20pm Bruce Hellman, CEO, Umotif
Quality of life directly from patients via a phone app
12:20pm - 1:00pm Ben Hwang, CEO, Profusa
Join the conversation...with your body. Continuous biometric monitoring
1:00pm - 2:00pm Lunch
2:00pm - 3:30pm Student presentations
i. Student Abstract Oral Presentation
  • Co-moderators: Irene Petersen, FISPE
ii. Student Abstract "Dynamic Posters"
  • Co-moderators: Debbie Layton & Sarah-Jo Sinnott
3:30pm3:50pm Break
3:50pm - 5:20pm Student presentations - 2 parallel sessions
iii. Student Abstract Oral Presentations
  • Co-Moderators: Ian Douglas & Juan Hincapie Castillo
iv. Student Abstract "Dynamic posters"
  • Co-Moderators: Annalisa Rubino & Amelia Smith
5:20pm Adjournment
5:20pm John Snow Presentation and Walk
John Snow (15 March 1813 - 16 June 1858) was an English physician and is considered one of the fathers of modern epidemiology, in part because of his work in tracing the source of a cholera outbreak in Soho, London, in 1854. There will be a short presentation at the end of the session on Monday before a guided walk (approximately 25 minutes) to the John Snow memorial and public house on Broadwick Street, Soho. Free and open to all, registration not necessary. Option to return in time to join the social event.
7:00pm Social Event (Registration Required)
Dinner at Mestizo - Restaurant and Tequila Bar

Tuesday
April 4, 2017
Scientific Symposium

Symposium Overview
With the advent of the Internet of Things, ubiquitous smart phones, and social media playing such a large role in peoples' lives, there is increasing opportunity for citizens to generate data relating to health, but do we capture such data and is it useful to us for pharmacoepidemiology? There is evolving interest in combining novel patient generated information with conventional Real Word Data generated from medical systems, and this meeting addresses how much insight the new data delivers and how acceptable it is for drug safety and outcomes research.

9:30am - 12:00pm Registration
9:30am - 10:10am Enrica Alteri, Head of Research & Development support Division at European Medicines Agency
How the EMA views new data sources
10:10am - 10:50am Andrew Roddam, Vice President & Global Head Epidemiology at GSK
How pharma views new data sources
10:50am - 11:15am Break
11:15am - 11:45am Sarah Garner, Associate Director NICE Science Policy and Research
Impact of new data on access
11:45am - 12:15pm Indra Joshi, Clinical Director, HealthTechWomen UK
Will Patient Generated Health Data Save the NHS or be the Final Straw?
12:15pm - 12:45pm Final Plenary Discussion - Bringing new data together with traditional thoroughness
  • Enrica Alteri, Head of Research & Development support Division at European Medicines Agency
  • Andrew Roddam, Vice President & Global Head Epidemiology at GSK
  • Sarah Garner, Associate Director NICE Science Policy and Research
  • Indra Joshi, Clinical Director, HealthTechWomen UK
12:45pm Final Comments
1:00pm Lunch & networking
2:30pm Adjournment